These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6783164)

  • 21. Association of pernicious anemia and intrinsic factor antibody with HLA-D.
    Thomsen M; Jørgensen F; Brandsborg M; Gimsing P; Nielsen JL; Ryder LP; Svejgaard A
    Tissue Antigens; 1981 Jan; 17(1):97-103. PubMed ID: 6166087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis.
    Chauhan B; Santiago L; Hutcheson PS; Schwartz HJ; Spitznagel E; Castro M; Slavin RG; Bellone CJ
    J Allergy Clin Immunol; 2000 Oct; 106(4):723-9. PubMed ID: 11031343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DR4 antigen and IgM rheumatoid factors.
    Queirós MV; Sancho MR; Caetano JM
    J Rheumatol; 1982; 9(3):370-3. PubMed ID: 6981703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of HLA-DR4 in melanoma patients from Alabama.
    Barger BO; Acton RT; Soong SJ; Roseman J; Balch C
    Cancer Res; 1982 Oct; 42(10):4276-9. PubMed ID: 6980704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD; Anhorn KA
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
    Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
    J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese.
    Tomura S; Kashiwabara H; Tuchida H; Shishido H; Sakurai S; Miyajima T; Tsuji K; Takeuchi J
    Nephron; 1984; 36(4):242-5. PubMed ID: 6424039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA A, B, C and DR antigens in young South African Indians with insulin-dependent diabetes mellitus.
    Omar MA; Hammond MG; Rajput MC; Asmal AC
    S Afr Med J; 1984 Nov; 66(20):765-7. PubMed ID: 6593838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association between the HL-A system and pernicious anaemia.
    Eastmond CJ; Woodrow JC
    Br J Haematol; 1976 May; 33(1):113-6. PubMed ID: 1268085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E; Umetsu D; Rosen F; Geha RS
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family studies in RA - the importance of HLA-DR4 and of genes for autoimmune thyroid disease.
    Grennan DM; Dyer PA; Clague R; Dodds W; Smeaton I; Harris R
    J Rheumatol; 1983 Aug; 10(4):584-9. PubMed ID: 6413686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR antigens in insulin-dependent diabetes.
    Schober E; Schernthaner G; Mayr WR
    Arch Dis Child; 1981 Mar; 56(3):227-9. PubMed ID: 7011215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of I and II class HLA antigens with Cushing's syndrome].
    Kalinin AP; Zaretskaia IuM; Andrusenko AB; Abramov VIu; Klinova EG; Bogatyrev OP; Donskov SI
    Klin Med (Mosk); 1991 Aug; 69(8):93-5. PubMed ID: 1724274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
    Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
    Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease.
    Mearin ML; Biemond I; Peña AS; Polanco I; Vazquez C; Schreuder GT; de Vries RR; van Rood JJ
    Gut; 1983 Jun; 24(6):532-7. PubMed ID: 6602084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of class II human histocompatibility leukocyte antigens with rheumatic fever.
    Ayoub EM; Barrett DJ; Maclaren NK; Krischer JP
    J Clin Invest; 1986 Jun; 77(6):2019-26. PubMed ID: 3486889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.